🎁
DIWALI SPECIAL

20% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

INDRAMEDCO vs NH: Stock Comparison

INDRAPRASTHA MEDICAL CORP vs NARAYANA HRUDAYALAYAUpdated 30 Oct 26, 10:56 AM ISTNSE & company filings

NARAYANA HRUDAYALAYA is the larger company by market capitalisation. INDRAPRASTHA MEDICAL CORP shows a lower P/E, a higher ROE and a higher dividend yield, while NARAYANA HRUDAYALAYA shows faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

INDRAMEDCO leads 8; NH leads 3 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

INDRAMEDCONH

Valuation lens

What price are you paying?

Market CapContext only
₹2,827 Cr
₹35,232 Cr
P/E RatioINDRAMEDCO has the lower reading
15.51x ✓
42.94x
P/B RatioINDRAMEDCO has the lower reading
3.94x ✓
7.72x
EPSINDRAMEDCO has the higher reading
₹20.51 ✓
₹10.14
Book ValueContext only
₹80.78
₹222.13
Dividend YieldINDRAMEDCO has the higher reading
1.28% ✓
0.26%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
NH is the larger company
₹35,232 Cr vs ₹2,827 Cr
P/E Ratio
INDRAMEDCO has a lower P/E
15.51x vs 42.94x
P/B Ratio
INDRAMEDCO has a lower P/B
3.94x vs 7.72x
EPS
INDRAMEDCO has higher earnings per share
₹20.51 vs ₹10.14
Dividend Yield
INDRAMEDCO has a higher dividend yield
1.28% vs 0.26%
Revenue Growth (TTM YoY)
NH has faster revenue growth
75.8% vs 9.3%
EPS Growth (TTM YoY)
NH has faster EPS growth
13.5% vs 1.8%
ROE
INDRAMEDCO has a higher ROE
24.8% vs 19.37%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricINDRAMEDCONH
SectorHealthcareHealthcare
IndustryHospitalHospital

Price

MetricINDRAMEDCONH
Live Price₹308.2₹1,723.1
Day Change-3.17%0.5%
Volume37,93623,388
52-Week High₹640.85₹2,093.3
52-Week Low₹293.65₹1,589
Distance from 52W High-51.91%-17.68%

Valuation

MetricINDRAMEDCONH
Market Cap₹2,827 Cr₹35,232 Cr
P/E Ratio15.51x42.94x
P/B Ratio3.94x7.72x
EPS₹20.51₹10.14
Book Value₹80.78₹222.13
Dividend Yield1.28%0.26%

Growth

MetricINDRAMEDCONH
Revenue Growth (TTM YoY)9.3%75.8%
EPS Growth (TTM YoY)1.8%13.5%
Qtr Sales Growth0%0%
Qtr Profit Growth0%0%

Profitability & Leverage

MetricINDRAMEDCONH
ROE24.8%19.37%
ROCE25.58%14.13%
Net Margin12.21%10.2%
Operating Margin17%19.6%
Debt to Equity0x0.71x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricINDRAMEDCONH
Promoter Holding49.39%58.27%▼ 5 pp
FII Holding2.39%▼ 0.38 pp9.01%▼ 0.39 pp
DII Holding1.77%▲ 1.18 pp10.68%▲ 1.62 pp
Public Holding44.84%▼ 0.8 pp16.42%▼ 1.23 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: INDRAPRASTHA MEDICAL CORP and NARAYANA HRUDAYALAYA.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.